Xiao-Ming Meng

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Venues

Journal of cellular and molecular medicine

Clinical science (London, England : 1979)

Science translational medicine

British journal of pharmacology

Anhui Medical University

Chinese University of Hong Kong (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Anhui Medical University Nov 01 2013

China

Professor :: School of Pharmacy

Education History

Chinese University of Hong Kong May 01 2009 - May 30 2012

Hong Kong

PHD :: Department of Medicine & Therapeutics and Li Ka Shing Institute of Health Sciences

Publications

Jia-Nan Wang, Fang Wang, Jing Ke, Zeng Li, Chuan-Hui Xu, Qin Yang, Xin Chen, Xiao-Yan He, Yuan He, Xiao-Guo Suo, Chao Li, Ju-Tao Yu, Ling Jiang, Wei-Jian Ni, Juan Jin, Ming-Ming Liu, Wei Shao, Chen Yang, Qian Gong, Hai-Yong Chen, Jun Li, Yong-Gui Wu, Xiao-Ming Meng
Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms. Science translational medicine 14 (640) (2022)
Jeff Yat-Fai Chung, Max Kam-Kwan Chan, Philip Chiu-Tsun Tang, Alex Siu-Wing Chan, Justin Shing-Yin Chung, Xiao-Ming Meng, Ka-Fai To, Hui Yao Lan, Kam-Tong Leung, Patrick Ming-Kuen Tang
AANG: A natural compound formula for overcoming multidrug resistance via synergistic rebalancing the TGF-β/Smad signalling in hepatocellular carcinoma. Journal of cellular and molecular medicine 25 (20) (2021)
Hong Zhou, Yan Fang, Tao Xu, Wei-Jian Ni, Ai-Zong Shen, Xiao-Ming Meng
Potential therapeutic targets and promising drugs for combating SARS-CoV-2. British journal of pharmacology 177 (14) (2020)
Li Gao, Xiang Zhong, Juan Jin, Jun Li, Xiao-Ming Meng
Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression. Signal transduction and targeted therapy 5 (1) (2020)
Juan Jin, Haolu Sun, Chao Shi, Hui Yang, Yiwan Wu, Wanhai Li, Yu-Hang Dong, Liang Cai, Xiao-Ming Meng
Circular RNA in renal diseases. Journal of cellular and molecular medicine 24 (12) (2020)
Jia-Nan Wang, Ming-Ming Liu, Fang Wang, Biao Wei, Qin Yang, Yu-Ting Cai, Xin Chen, Xue-Qi Liu, Ling Jiang, Chao Li, Xiao-Wei Hu, Ju-Tao Yu, Tao-Tao Ma, Juan Jin, Yong-Gui Wu, Jun Li, Xiao-Ming Meng
RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress. Clinical science (London, England : 1979) 133 (14) (2019)
Gui-Ling Ren, Jie Zhu, Jun Li, Xiao-Ming Meng
Noncoding RNAs in acute kidney injury. Journal of cellular physiology 234 (3) (2018)

Xiao-Ming Meng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiao-Ming Meng